Mitsubishi UFJ Capital
Signal active
Investment Firm
Overview
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Highlights
Founded
1974
Industry
Financial Services
Employees
51-100
Investment
536
Lead Investment
63
Exits
80
Stages
Late Stage Venture, Early Stage Venture, Seed, Private Equity
Investor Type
Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Mitsubishi UFJ Capital, established in 1974 and headquartered in Asia., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Biopharma, Financial Services, Venture Capital, Life Science, Oncology, Finance, Energy. The organization boasts a portfolio of 532 investments, with an average round size of $8.3M and 80 successful exits. Their recent investments include Humanigen, Alloy Ventures, GBS Ventures, MPM Capital, Sofinnova Investments. The highest investment round they participated in was $309.2B. Among their most notable exits are Humanigen and Alloy Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Mitsubishi UFJ Capital has made 536 investments. Their most recent investment was on Aug 06, 2024, when Shinobi Therapeutics raised $68.0M.
Mitsubishi UFJ Capital has made 7 diversity investments. Their most recent diversity investment was on Aug 25, 2020, when DiscGenics raised $50.0M.
investments
536
Diversity investments
7
Lead investments
63
Number of exits
80
Investments
536
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 19, 2024 | Jubo | Information Technology | 7.6M |
| Aug 05, 2024 | Secai Marche | B2B | 2.1M |
| Aug 05, 2024 | Equmenopolis | Information Services | null |
| Aug 06, 2024 | Shinobi Therapeutics | Biotechnology | 68.0M |
Exits
80
Funding Timeline
Funding rounds
536
Investors
0
Funds
8
Funding Rounds
536
Mitsubishi UFJ Capital has raised 536 rounds. Their latest funding was raised on Aug 06, 2024 from a Series A - Shinobi Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 19, 2024 | Series B - Jubo | - | 7.6M | - |
| Aug 05, 2024 | Series A - Secai Marche | - | 2.1M | - |
| Aug 05, 2024 | Seed Round - Equmenopolis | - | 0 | - |
| Aug 06, 2024 | Series A - Shinobi Therapeutics | - | 68.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.